Enovix
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 5 months.
- Recent price momentum is -73.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 23.0% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability D-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 19.2% | Better than 17% |
| Operating margin | -557.0% | Better than 4% |
| Net margin | -492.6% | Better than 3% |
| Return on equity | -60.5% | Better than 8% |
| Return on invested capital | -23.7% | Better than 12% |
Momentum F
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -65.4% | Better than 2% |
| 6-month return | -82.5% | Better than 1% |
| 12-month return (ex latest month) | -62.7% | Better than 1% |
| Distance below 52-week high | 87.3% | Better than 1% |
Financial Health C-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 8.3x | Better than 92% |
| Debt to assets | 61.5% | Better than 8% |
| Interest coverage | -6.3x | Better than 15% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 33.3% | Better than 15% |
| Upside to average target | 455.6% | Better than 99% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 1.29
- Open
- 1.27
- Day range
- 1.13 - 1.33
- Avg price
- 1.19
- Volume
- 9.68M
- Turnover
- 11.48M
- Turnover ratei
- 5.15%
- Volume ratioi
- 0.81
- Amplitudei
- 15.50%
- 52-week rangei
- 1.13 - 9.19
Valuation
- P/Ei
- -1.56
- P/E (TTM)i
- -1.63
- P/Bi
- 1.47
- EPSi
- -0.75
- Book value / shi
- 0.80
- Net profit
- -159.36M
- Net assets
- 169.13M
Share structure
- Market cap
- 248.60M
- Float capi
- 220.04M
- Shares out
- 212.48M
- Float sharesi
- 188.07M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
87.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-6.25M net over the window
Short interest
- Shares short
- 50.43M
- % of floati
- 22.98%
- Days to coveri
- 4.11
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Enovix (ENVX)?
Enovix last traded at 1.17. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Enovix's market cap?
About 248.60M.
What is the P/E ratio of Enovix?
The trailing twelve-month P/E is -1.63. The Valuation tab shows it against the stock's own five-year range.
Does Enovix pay a dividend?
Enovix does not currently pay a regular dividend.
Is Enovix a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 6.50, which implies 455.6% upside from the current price. This is not investment advice.
What is Enovix's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Enovix a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Enovix discussion 0 comments